Â鶹ŮÀÉ

The mission of the David and Lynn Nicholson Center for Neurodegenerative Disease Research is to pioneer transformative research on neurodegenerative diseases and enable the discovery and development of life-saving treatments for Alzheimer's disease and related dementias, Parkinson's disease, amyotrophic lateral sclerosis and other degenerative diseases of the central nervous system. The center will foster synergies between teams with complementary expertise, thereby accelerating research and advances in diagnostic, prevention and therapeutic development. The center reflects Â鶹ŮÀÉ’s dynamic development and commitment to bringing premier research and academic medicine to Southeast Florida.

The Center for Neurodegenerative Disease Research will provide the technological, intellectual, educational, medical and collaborative environment to perform cutting-edge research, support Florida Atlantic and affiliated investigators, attract new talent, and will enhance the potential for rapid advancement of existing and future programs towards clinical applications. The center’s activities will contribute to the mission of the Stiles-Nicholson Brain Institute to bridge neuroscience and public understanding of science and will foster sustained federal, foundation and individual philanthropic financial support to fuel discovery and disease intervention. The center's basic and translational research output will strongly support Florida Atlantic’s commitment and actions to enhance health and quality of life in our community and nationwide.

David and Lynn Nicholson Center for Neurodegenerative Disease Research

Research and Clinical Affiliates

Research Affiliates

Thomas Bannister, Ph.D., Research Professor and Senior Scientific Director, Department of Chemistry and Department of Molecular Medicine, The Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, Florida

Gogce C. Crynen, Ph.D., Director of the Bioinformatics and Statistics Core, The Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, Florida

Holger Wille, Ph.D., Professor, Department of Biochemistry, Director of the Centre for Prions and Protein Folding Diseases, University of Alberta, Canada

Clinical Affiliates

Lloyd Zucker, MD, FAANS, Brain and Spine Center of South Florida, Chief of Neurosurgery, Delray Medical Center, Attending Neurosurgeon, Boca Raton Regional Hospital, Clinical Research Professor, Â鶹ŮÀÉ Institute of Human Health and Disease Intervention, Affiliate Assistant Professor, Â鶹ŮÀÉ Charles E. Schmidt College of Medicine

Arif Dalvi, MD, MBA, Director of the Comprehensive Movement Disorders Program, Palm Beach Neuroscience Institute, and of the Memory Disorders Program, St. Mary's Medical Center